White House Launches TrumpRx Platform to Facilitate Discounted Medicine Purchases
The Trump administration has launched TrumpRx, a direct-to-consumer (DTC) platform aimed at reducing medicine prices in the United States. The platform serves as a hub directing consumers to various DTC channels offering discounted prices on medicines, but it does not sell drugs directly. TrumpRx features medicines from manufacturers who have reached most-favored nation pricing deals with the administration, including AstraZeneca, Eli Lilly, Merck/EMD Serono, Novo Nordisk, and Pfizer. The platform targets cash-paying customers, offering discounts on over 40 medicines for chronic conditions such as asthma, diabetes, and obesity. However, the platform's effectiveness in lowering drug prices for insured patients remains unclear.